Over the last 13 years, we have written on and covered thousands of companies that possess important technologies. Some have helped revolutionize industries and others in the medical space have helped save lives. As relevant as many of those companies’ offerings were, the technology of BeesFree, Inc. (OTCBB: BEES) just may be one of the most critical to life on Earth that we have ever focused upon. Bees are a crucial component of our environment and, while many people may only think of them as the little stingers that can be a nuisance, they literally breathe life into the global ecosystem. Their pollinating efforts are the foundation of the vast majority of the agriculture industry and responsible for $15 billion in added crop value, particularly for specialty crops such as almonds and other nuts, berries, fruits, and vegetables. Unfortunately, their existence and all that depends upon it, is in jeopardy as a result of an unexplained phenomenon known as Colony Collapse Disorder, or CCD.
No one can exactly pin-down the reason why very socially-oriented adult bees are disappearing from the hive; leaving behind the queen and immature brood with no one to tend to them and simply vanishing. CCD has been running rampant for nearly six years now with reports from several continents, including North America, registering losses in bee colonies that tally between 30 and 90 percent. Regarded as “a most important” species on the planet, something has got to be done to put an end to CCD, a disorder more threatening to mankind than the most serious forms of cancer and heart diseases combined.
The good news is that governments have taken action and are spending millions to try and understand and prevent CCD and BeesFree has developed technologies and products that are now being commercialized to help save the global bee population. BeesFree has incorporated decades of experience from experts in the beekeeping, zoology and microbiology sciences to develop a patent-pending formula and comprehensive CCD preventative (and possibly eradicative) system. Focused on the strengthening bees’ immune systems and targeting several of the potential culprits underlying CCD, the revolutionary technology utilizes a chemical compound containing natural elements extracted from pure vegetable sources to combat parasites and chemicals in pesticides while also providing nutrients to the bees.
The formulation will only work if the bees ingest it, which is why BeesFree scientists have developed the “Beespenser,” a fully-automated system that naturally attracts bees and gives them a perfect environment for eating and drinking the special, life-saving formula.
BeesFree’s patent-pending formula and delivery system are presently the only integrated solution available to combat the known effects of CCD in a global market whose size measures between $2 and $3 billion. Given the criticalness of the CCD situation, it would not be a stretch to foresee the products being a raging success as there is simply nothing else out there like it. Shortly after patent protection documentation was filed in Argentina by BeesFree, the first order followed. The initial order was valued at $100,000. Argentina is acutely interested in the technology with their National Institute of Agricultural Technology, a government agency that looks after sustainability in all agricultural businesses and segments, conducting an extensive study on hundreds of beehives to test the effectiveness of the BeesFree’s patent-pending technology in Argentine climates.
BeesFree’s has now filed for protection of its Intellectual Property via the WIPO (World Intellectual Property Organization) which will protect its technologies across the more than 140 countries/states belong to the Patent Cooperation Treaty.
The potential magnitude of uses for BeesFree products could simply mushroom its market cap – which currently stands at only $37.14 million – as commercialization is escalated and word of its effectiveness resonates across the globe. While the new products of some companies can struggle to gain market share in competitive industries, BeesFree’s products are simply too important to overlook and have no competition, putting this junior firm in a very enviable position with an unprecedented upside. Proper due diligence of the company and CCD is, as always, encouraged.
Article originally posted on AllPennyStocks.com.
BeesFree (BEES) Stock Quote and News:
Disclaimer: Neither http://www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article from and owns no shares of the aforementioned company(ies). Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/about-2/disclaimer.